MedWatch

EMA: We're firmly convinced of the benefits of the Astrazeneca vaccine

The EMA is investigating reports of blood clots following the Astrazeneca vaccine, but does not change its recommendation.

Photo: PIROSCHKA VAN DE WOUW/REUTERS / X06750

The European Medicines Agency (EMA) remains "highly convinced" that the benefits of the Astrazeneca vaccine outweigh its risks, according to EMA Executive Director Emer Cooke at a Tuesday press conference.

"We are still firmly convinced that the benefits of the Astrazeneca vaccine in preventing Covid-19 with its associated risk of hospitalization and death outweigh the risk of these side effects," she says.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs